Boundless Bio, Inc. (BOLD)
NASDAQ: BOLD · Real-Time Price · USD
2.830
-0.030 (-1.05%)
At close: Aug 28, 2026, 4:00 PM EDT
2.850
+0.020 (0.71%)
After-hours: Aug 28, 2026, 7:30 PM EDT
Boundless Bio Market Cap
Boundless Bio has a market cap or net worth of $64.37 million as of August 28, 2026. Its market cap has increased by 152.26% in one year.
Market Cap
64.37M
Enterprise Value
-8.25M
1-Year Change
152.26%
Ranking
Category
Stock Price
$2.83
ChartMarket Cap Chart
Since the IPO on March 28, 2024, Boundless Bio's market cap has decreased from $355.83M to $64.37M, a decrease of -81.91%. That is a compound annual growth rate of -50.68%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 64.37M | 139.65% |
| Dec 31, 2025 | 26.86M | -58.46% |
| Dec 31, 2024 | 64.67M | -81.83% |
| Mar 28, 2024 | 355.83M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| XBiotech | 70.12M |
| eXoZymes | 69.89M |
| PMV Pharmaceuticals | 69.76M |
| Champions Oncology | 69.19M |
| Rein Therapeutics | 69.01M |
| Serina Therapeutics | 68.58M |
| BioStem Technologies | 68.01M |
| INmune Bio | 67.44M |